79 related articles for article (PubMed ID: 22085765)
1. Glycyrrhetinic acid protects mice from Staphylococcus aureus pneumonia.
Li HE; Qiu JZ; Yang ZQ; Dong J; Wang JF; Luo MJ; Pan J; Dai XH; Zhang Y; Song BL; Deng XM
Fitoterapia; 2012 Jan; 83(1):241-8. PubMed ID: 22085765
[TBL] [Abstract][Full Text] [Related]
2. Pneumonia due to Staphylococcus aureus infection.
al-Ujayli B; Nafziger DA; Saravolatz L
Clin Chest Med; 1995 Mar; 16(1):111-20. PubMed ID: 7768084
[TBL] [Abstract][Full Text] [Related]
3. Artesunate protects sepsis model mice challenged with Staphylococcus aureus by decreasing TNF-alpha release via inhibition TLR2 and Nod2 mRNA expressions and transcription factor NF-kappaB activation.
Li B; Li J; Pan X; Ding G; Cao H; Jiang W; Zheng J; Zhou H
Int Immunopharmacol; 2010 Mar; 10(3):344-50. PubMed ID: 20005985
[TBL] [Abstract][Full Text] [Related]
4. Silibinin in vitro protects A549 cells from Staphylococcus aureus-mediated injury and in vivo alleviates the lung injury of staphylococcal pneumonia.
Wang X; Dong J; Dai X; Zhang Y; Wang J; Li H; Lu C; Tan W; Gao X; Deng X; Bu S; Niu X
Planta Med; 2013 Jan; 79(2):110-5. PubMed ID: 23299760
[TBL] [Abstract][Full Text] [Related]
5. Chrysin protects mice from Staphylococcus aureus pneumonia.
Wang J; Qiu J; Dong J; Li H; Luo M; Dai X; Zhang Y; Leng B; Niu X; Zhao S; Deng X
J Appl Microbiol; 2011 Dec; 111(6):1551-8. PubMed ID: 21972890
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo activities of echinomycin against clinical isolates of Staphylococcus aureus.
Park YS; Shin WS; Kim SK
J Antimicrob Chemother; 2008 Jan; 61(1):163-8. PubMed ID: 17967852
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory Peptide IDR-1018 Decreases Implant Infection and Preserves Osseointegration.
Choe H; Narayanan AS; Gandhi DA; Weinberg A; Marcus RE; Lee Z; Bonomo RA; Greenfield EM
Clin Orthop Relat Res; 2015 Sep; 473(9):2898-907. PubMed ID: 25953690
[TBL] [Abstract][Full Text] [Related]
8. Subinhibitory concentrations of farrerol reduce α-toxin expression in Staphylococcus aureus.
Qiu J; Xiang H; Hu C; Wang Q; Dong J; Li H; Luo M; Wang J; Deng X
FEMS Microbiol Lett; 2011 Feb; 315(2):129-33. PubMed ID: 21175745
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous vancomycin-resistant Staphylococcus aureus (hetero-VISA) in Singapore.
Sng LH; Koh TH; Wang GC; Hsu LY; Kapi M; Hiramatsu K
Int J Antimicrob Agents; 2005 Feb; 25(2):177-9. PubMed ID: 15664490
[No Abstract] [Full Text] [Related]
10. Baicalin protects mice from Staphylococcus aureus pneumonia via inhibition of the cytolytic activity of α-hemolysin.
Qiu J; Niu X; Dong J; Wang D; Wang J; Li H; Luo M; Li S; Feng H; Deng X
J Infect Dis; 2012 Jul; 206(2):292-301. PubMed ID: 22551812
[TBL] [Abstract][Full Text] [Related]
11. Liquiritigenin prevents Staphylococcus aureus-mediated lung cell injury via inhibiting the production of α-hemolysin.
Dai XH; Li HE; Lu CJ; Wang JF; Dong J; Wei JY; Zhang Y; Wang X; Tan W; Deng XM; Zhao SH; Zhang MJ
J Asian Nat Prod Res; 2013; 15(4):390-9. PubMed ID: 23464667
[TBL] [Abstract][Full Text] [Related]
12. Protection of Staphylococcus aureus-infected septic mice by suppression of early acute inflammation and enhanced antimicrobial activity by ginsan.
Ahn JY; Song JY; Yun YS; Jeong G; Choi IS
FEMS Immunol Med Microbiol; 2006 Mar; 46(2):187-97. PubMed ID: 16487300
[TBL] [Abstract][Full Text] [Related]
13. Isoalantolactone protects against Staphylococcus aureus pneumonia.
Qiu J; Luo M; Wang J; Dong J; Li H; Leng B; Zhang Q; Dai X; Zhang Y; Niu X; Deng X
FEMS Microbiol Lett; 2011 Nov; 324(2):147-55. PubMed ID: 22092816
[TBL] [Abstract][Full Text] [Related]
14. Subinhibitory concentrations of pinocembrin exert anti-Staphylococcus aureus activity by reducing α-toxin expression.
Soromou LW; Zhang Y; Cui Y; Wei M; Chen N; Yang X; Huo M; Baldé A; Guan S; Deng X; Wang D
J Appl Microbiol; 2013 Jul; 115(1):41-9. PubMed ID: 23594163
[TBL] [Abstract][Full Text] [Related]
15. Effect of subinhibitory concentrations of chlorogenic acid on reducing the virulence factor production by Staphylococcus aureus.
Li G; Qiao M; Guo Y; Wang X; Xu Y; Xia X
Foodborne Pathog Dis; 2014 Sep; 11(9):677-83. PubMed ID: 24905974
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid binding peptides prevent experimental staphylococcal wound infection.
Zaleski KJ; Kolodka T; Cywes-Bentley C; McLoughlin RM; Delaney ML; Charlton BT; Johnson W; Tzianabos AO
Antimicrob Agents Chemother; 2006 Nov; 50(11):3856-60. PubMed ID: 17065624
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial activity of thionin Thi2.1 from Arabidopsis thaliana expressed by bovine endothelial cells against Staphylococcus aureus isolates from bovine mastitis.
Ochoa-Zarzosa A; Loeza-Angeles H; Sagrero-Cisneros E; Villagómez-Gómez E; Lara-Zárate L; López-Meza JE
Vet Microbiol; 2008 Mar; 127(3-4):425-30. PubMed ID: 17961938
[TBL] [Abstract][Full Text] [Related]
18. Vascular allografts are resistant to methicillin-resistant Staphylococcus aureus through indoleamine 2,3-dioxygenase in a murine model.
Saito A; Motomura N; Kakimi K; Narui K; Noguchi N; Sasatsu M; Kubo K; Koezuka Y; Takai D; Ueha S; Takamoto S
J Thorac Cardiovasc Surg; 2008 Jul; 136(1):159-67. PubMed ID: 18603069
[TBL] [Abstract][Full Text] [Related]
19. In vitro antimicrobial effect and in vivo preventive and therapeutic effects of partially purified lantibiotic lacticin NK34 against infection by Staphylococcus species isolated from bovine mastitis.
Kim SY; Shin S; Koo HC; Youn JH; Paik HD; Park YH
J Dairy Sci; 2010 Aug; 93(8):3610-5. PubMed ID: 20655430
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel anti-multidrug-resistant staphylococcus aureus derivatives of glycyrrhetinic acid by blocking arginine biosynthesis, metabolic and H
Cai DS; Yang XY; Yang YQ; Gao F; Cheng XH; Zhao YJ; Qi R; Zhang YZ; Lu JH; Lin XY; Liu YJ; Xu B; Wang PL; Lei HM
Bioorg Chem; 2023 Feb; 131():106337. PubMed ID: 36603244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
